Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial.
Saved in:
| Title: | Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial. |
|---|---|
| Authors: | Böhm M; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Saarland, Germany.; Cape Heart Institute, Cape Town, South Africa., Butler J; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA.; Baylor Scott and White Research Institute, Dallas, Texas, USA., Mahfoud F; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Saarland, Germany., Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece., Ferreira JP; Centre d'Investigation Clinique- Plurithématique Inserm CIC-P 1433, Université de Lorraine, Nancy, France.; France Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France., Pocock SJ; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK., Slawik J; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Saarland, Germany., Brueckmann M; Boehringer Ingelheim International, Ingelheim, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Linetzky B; Eli Lilly Interamerica Inc, Suc Argentina, Buenos Aires, Argentina., Schüler E; mainanalytics GmbH, Sulzbach/Taunus, Germany., Wanner C; Medizinische Klinik und Poliklinik 1, Schwerpunkt Nephrologie, Universitätsklinikum Würzburg, Würzburg, Germany., Zannad F; Centre d'Investigation Clinique- Plurithématique Inserm CIC-P 1433, Université de Lorraine, Nancy, France.; France Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France., Packer M; Baylor University Medical Center, Dallas, TX, USA.; Imperial College, London, UK., Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany. |
| Corporate Authors: | EMPEROR-Preserved Trial Committees and Investigators |
| Source: | European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1883-1891. Date of Electronic Publication: 2022 Oct 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1879-0844 |
|---|---|
| DOI: | 10.1002/ejhf.2677 |